Category: Medications - Page 4

Generic Drug Savings: Real Numbers and Healthcare Statistics

Keith Ashcroft
|
December 12
|
9

Generic drugs save Americans billions each year-90% of prescriptions are generic, but they cost just 12% of what brand-name drugs do. See the real numbers behind the savings, how generics work, and why some drugs still cost too much.

Macrolide Antibiotics and Heart Arrhythmias: What You Need to Know About QT Prolongation Risk

Keith Ashcroft
|
December 10
|
8

Macrolide antibiotics like azithromycin and clarithromycin can cause QT prolongation and dangerous heart rhythms. Learn who's at risk, how to spot warning signs, and what safer alternatives exist.

Stability Testing: Long-Term Quality Monitoring Post-Manufacture in Pharmaceuticals

Keith Ashcroft
|
December 9
|
13

Stability testing ensures pharmaceuticals remain safe and effective after manufacture. Learn how ICH guidelines, real-time monitoring, and AI are shaping long-term quality control in drug production.

How the FDA Ensures Generic Drug Safety Through Manufacturing Oversight

Keith Ashcroft
|
December 7
|
13

The FDA ensures generic drug safety through strict manufacturing standards, bioequivalence testing, and global inspections. Learn how generics are monitored from factory to pharmacy.

Hydrophilic vs Lipophilic Statins: What You Need to Know About Side Effects

Keith Ashcroft
|
December 3
|
8

Hydrophilic and lipophilic statins differ in how they move through the body, affecting muscle pain risk and drug interactions. Learn which statins are safer, what really causes side effects, and how to choose the right one for you.

State Laws on Generic Drug Substitution: What Pharmacists and Patients Need to Know

Keith Ashcroft
|
December 1
|
10

State laws on generic drug substitution vary widely across the U.S., affecting how pharmacists swap brand-name drugs for generics. Learn how consent rules, NTI drug restrictions, and biosimilar policies differ by state-and what patients and pharmacists need to know.

180-Day Exclusivity in Generic Drug Market Entry: How Patent Law Controls Access

Keith Ashcroft
|
December 1
|
11

The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug maker to challenge a patent a temporary monopoly - but it often delays competition and keeps prices high. Here’s how it works, why it’s controversial, and what’s being done to fix it.

Metformin and Vitamin B12 Deficiency: What You Need to Know About Long-Term Risks

Keith Ashcroft
|
December 1
|
12

Long-term metformin use can cause vitamin B12 deficiency, leading to nerve damage, fatigue, and confusion. Learn the symptoms, who's at risk, and how to prevent irreversible complications with simple blood tests and supplements.

Antiemetics and Parkinson’s Medications: Avoiding Dangerous Dopamine Interactions

Keith Ashcroft
|
November 27
|
10

Dopamine-blocking antiemetics like metoclopramide can severely worsen Parkinson’s symptoms. Learn which drugs to avoid, safer alternatives like domperidone and cyclizine, and how to protect your movement from dangerous medication interactions.

Fixed-dose combination drugs: what they are and why they exist

Keith Ashcroft
|
November 24
|
13

Fixed-dose combination drugs combine two or more medications in one pill to improve adherence, reduce pill burden, and enhance treatment effectiveness. Learn how they work, where they're used, and when they make sense.